Physician profile
Michael D Conte
NPI 1417951179
$3,400.04
in general payments reported to CMS, 2019-2025
17 companies · $583 in 2025
The $583 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $121 · 2021: $413 · 2022: $366 · 2023: $671 · 2024: $675 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $574.65 | 2022-2025 | |
| Alcon Vision LLC | $421.39 | 2019-2025 | Dailies Total1, Precision7 |
| Coopervision INC. | $389.50 | 2021-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $348.28 | 2019-2021 | |
| Oyster Point Pharma, INC. | $236.62 | 2022-2024 | Tyrvaya |
| Lkc Technologies, INC. | $214.88 | 2023-2025 | |
| Abbvie INC. | $182.05 | 2022-2023 | Vuity, Lumigan |
| Abb Con-Cise Optical Group LLC | $163.67 | 2022-2025 | Spectacle Lenses, Contact Lens |
| Maculogix, INC. | $153.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $138.35 | 2019 | |
| Glaukos Corporation | $137.20 | 2024 | Radius |
| Bausch & Lomb Americas INC. | $123.05 | 2023 | Btod, Infuse |
| Optos, INC. | $95.65 | 2019 | |
| Dompe US, INC. | $90.07 | 2024-2025 | Oxervate |
| Sight Sciences, INC. | $52.07 | 2020-2025 | Tearcare System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $41.82 | 2019 | |
| Allergan, INC. | $37.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Conte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.